Provided by Tiger Fintech (Singapore) Pte. Ltd.

OCUMENSION-B

8.460
+0.1101.32%
Volume:689.50K
Turnover:5.83M
Market Cap:6.89B
PE:-19.76
High:8.560
Open:8.270
Low:8.250
Close:8.350
52wk High:12.230
52wk Low:3.620
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.46
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.428
ROE:-7.76%
ROA:-5.07%
PB:1.73
PE(LYR):-19.76
PS:11.62

Loading ...

70 Million Yuan Acquisition: China Resources Group Makes Another Move

Deep News
·
Sep 29

New Drug Tariffs "Much Ado About Nothing"? UBS: Major Pharma Companies Have Invested Hundreds of Billions in US, Can Get Full Exemptions

Stock News
·
Sep 27

Breaking "Black Swan" Event! Pharmaceutical Sector Plunges Collectively

Deep News
·
Sep 26

Trump Brandishes Tariff Weapon Again: 100% Tariffs on Patented and Branded Drugs Starting October 1

Stock News
·
Sep 26

Novartis AG (NVS.US) CD20-Targeting Therapy Maintains High Efficacy for Up to 7 Years with Patient Self-Injection Option

Stock News
·
Sep 26

Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 5% Again as AIDD Industry Accelerates, Company Leads AI Pharmaceutical Development

Stock News
·
Sep 25

Eli Lilly Announces New Pharmaceutical Facility in Texas to Boost Weight-Loss Drug Production Amid Surging Demand

Stock News
·
Sep 24

ASCLETIS-B (01672) Issues 314,000 Shares Following Stock Option Exercises

Stock News
·
Sep 23

Roche Reports Positive Late-Stage Trial Results for Breast Cancer Drug Combination

Deep News
·
Sep 22

ASCLETIS-B (01672): ASC47 Combined with Semaglutide Demonstrates Up to 56.2% Relative Improvement in Weight Loss Efficacy Compared to Semaglutide Monotherapy in Obese Subjects

Stock News
·
Sep 22

Trump Administration Develops Prescription Drug Direct-Sales Platform: Bypassing Pharmacies to Drive Down Drug Prices

Deep News
·
Sep 20

Why We're Not Concerned Yet About Ocumension Therapeutics' (HKG:1477) 26% Share Price Plunge

Simply Wall St.
·
Sep 19

ASCLETIS-B (01672) Issues 295,600 Shares Following Stock Option Exercises

Stock News
·
Sep 18

ASCLETIS-B (01672) Reports Breakthrough Phase III Results for First-in-Class FASN Inhibitor Denifanstat (ASC40) in Acne Treatment at 2025 EADV Annual Meeting

Stock News
·
Sep 18

Hong Kong Stocks Movement | ASCLETIS-B (01672) Surges Over 5% as ASC30 Demonstrates Superior Efficacy and Safety Profile with Multiple Catalysts Expected in Second Half

Stock News
·
Sep 17

British Pharmaceutical Giant GlaxoSmithKline Announces $30 Billion Investment in the US

Deep News
·
Sep 17

ASCLETIS-B (01672) Reports Results from Cohorts 1 and 2 of 28-Day Multiple Ascending Dose Study of ASC30 Oral Small Molecule GLP-1R Agonist at 61st European Association for the Study of Diabetes Annual Meeting

Stock News
·
Sep 17

BAIYUNSHAN PH (00874) Subsidiary Receives Drug Supplementary Application Approval Certificates

Stock News
·
Sep 16

Tiansheng Pharmaceutical Investigation Concludes, False Annual Reports Trigger Compensation Claims

Deep News
·
Sep 15

Hong Kong Stock Alert | ASCLETIS-B (01672) Surges Over 4% in Afternoon Trading as Clinical Data Shows Ultra-Long Half-Life, ASC30 Poised for Quarterly Formulation

Stock News
·
Sep 15